Founded in 2002, BioSurplus is a preeminent buyer and seller of lab equipment. The company’s CEO, Bill VanDeWeghe will now serve as chief executive officer of Copia Scientific.
“Consolidating the capabilities of these companies creates a platform for further expansion focused on better serving our customers,” VanDeWeghe said. “This merger comes at a time of great need for the growing and expanding life science industry.”
The combined company will be headquartered in Taunton, Mass. with additional West Coast operations in San Diego to serve the entire country as well as international customers.
“Copia will lead the industry in providing superior products, exceptional customer service, and unparalleled support to growing and existing companies in desperate need of the tools they require to be successful,” said Rich Tula, Copia Scientific president, the former Biodirect CEO. “Entering into a partnership with two like-minded companies is a gamechanger for us and our customers.”
Copia Scientific will begin immediately hiring nationally for a number of positions including San Diego and particularly in Massachusetts. The combined company will serve as an expert in liquid handling, laboratory automation, microscopy, flow cytometry, detection technologies and more along with a suite of asset management services including auctions and asset disposition solutions.
“The consolidation of three leading vendors addresses industry-wide fragmentation and immediately establishes a peerless service provider offering a wide range of instrumentation, method development and field service, supporting the entire equipment life cycle,” said Bryan Hoffman, former CEO of Boston Microscopes who will take on the role of chief revenue officer with Copia Scientific.